Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Page 1
Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients.
Latorre M, Rizzi A, Paggiaro P, Baiardini I, Bagnasco D, DelGiacco S, Lombardi C, Patella V, Nucera E, Parente R, Paoletti G, Pini L, Ridolo E, Senna G, Blasi F, Canonica GW, Aruanno A, Ballacchino C, Bonavia M, Calabrese C, Caminati M, Carbonara M, Cardini C, Caruso C, Cattani L, Crivellaro MA, Diana A, Durante E, Favero E, Barbaro MPF, Frateiacci S, Guarnieri G, Lofaro A, Losa F, Magarò N, Menzella F, Ricciardi L, Scioscia G, Testino E, Torracca F. Latorre M, et al. Among authors: blasi f. J Asthma. 2024 Apr 5:1-26. doi: 10.1080/02770903.2024.2338863. Online ahead of print. J Asthma. 2024. PMID: 38578082
Patients were fairly satisfied with asthma therapies, but many had concerns about long-term corticosteroid use. Patients complained about poor management of comorbidities associated with asthma and OCS use, but were generally satisfied with their patient/doctor relationshi …
Patients were fairly satisfied with asthma therapies, but many had concerns about long-term corticosteroid use. Patients complained a …
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review.
Bongiovanni G, Tonutti A, Stainer A, Nigro M, Kellogg DL 3rd, Nambiar A, Gramegna A, Mantero M, Voza A, Blasi F, Aliberti S, Amati F. Bongiovanni G, et al. Among authors: blasi f. BMJ Open Respir Res. 2024 Mar 13;11(1):e002161. doi: 10.1136/bmjresp-2023-002161. BMJ Open Respir Res. 2024. PMID: 38479818 Free PMC article.
Unfortunately, the salient studies are limited by population heterogeneity, short-term follow-up and the selection of outcomes with uncertain clinical significance. ...
Unfortunately, the salient studies are limited by population heterogeneity, short-term follow-up and the selection of outcomes with u …
Long-Term Outcomes in Severe Community-Acquired Pneumonia.
Carella F, Aliberti S, Stainer A, Voza A, Blasi F. Carella F, et al. Among authors: blasi f. Semin Respir Crit Care Med. 2024 Apr;45(2):266-273. doi: 10.1055/s-0044-1781426. Epub 2024 Feb 23. Semin Respir Crit Care Med. 2024. PMID: 38395062 Review.
Severe CAP (sCAP) presents great challenges and need a comprehensive understanding of its long-term outcomes. Cardiovascular events and neurological impairment, due to persistent inflammation and hypoxemia, contribute to long-term outcomes in CAP, including mortalit …
Severe CAP (sCAP) presents great challenges and need a comprehensive understanding of its long-term outcomes. Cardiovascular events a …
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.
Bagnasco D, Nicola S, Testino E, Brussino L, Pini L, Caminati M, Piccardo F, Canevari RF, Melissari L, Ioppi A, Guastini L, Lombardi C, Milanese M, Losa F, Robbiano M, De Ferrari L, Riccio AM, Guida G, Bonavia M, Fini D, Balbi F, Caruso C, Paggiaro P, Blasi F, Heffler E, Paoletti G, Canonica GW, Senna G, Passalacqua G, On Behalf Of Sani. Bagnasco D, et al. Among authors: blasi f. Biomedicines. 2023 Aug 30;11(9):2424. doi: 10.3390/biomedicines11092424. Biomedicines. 2023. PMID: 37760865 Free PMC article.
Primarily to study the effect of mepolizumab on exacerbations, steroid dependence, and the continuation of efficacy in the long term. Secondarily to evaluate the effect of the drug on nasal polyps. ...Patients with concomitant nasal polyps, assessed by SNOT-22, showed a 49 …
Primarily to study the effect of mepolizumab on exacerbations, steroid dependence, and the continuation of efficacy in the long term. …
Hemodynamic failure and graft dysfunction after lung transplant: A possible clinical continuum with immediate and long-term consequences.
Scaravilli V, Guzzardella A, Madotto F, Morlacchi LC, Bosone M, Bonetti C, Musso V, Rossetti V, Russo FM, Sorbo LD, Blasi F, Nosotti M, Zanella A, Grasselli G. Scaravilli V, et al. Among authors: blasi f. Clin Transplant. 2023 Dec;37(12):e15122. doi: 10.1111/ctr.15122. Epub 2023 Sep 11. Clin Transplant. 2023. PMID: 37694497 Free article.
Postoperative hemodynamic dysfunction requiring vasopressor support and graft dysfunction may represent a clinical continuum with immediate and long-term consequences. Further studies may elucidate if this represents a possible treatable condition....
Postoperative hemodynamic dysfunction requiring vasopressor support and graft dysfunction may represent a clinical continuum with immediate …
Unplanned pregnancies following the introduction of elexacaftor/tezacaftor/ivacaftor therapy in women with cystic fibrosis.
Daccò V, Alicandro G, Trespidi L, Gramegna A, Blasi FA. Daccò V, et al. Among authors: blasi fa. Arch Gynecol Obstet. 2023 Nov;308(5):1657-1659. doi: 10.1007/s00404-023-07153-y. Epub 2023 Jul 30. Arch Gynecol Obstet. 2023. PMID: 37517074
The perception of subfertility developed by women with CF over time, before the era of modulators, can influence their long-term habits and lead to the underuse of contraceptive methods. While further research is needed to fully understand the effects of ETI on fertility, …
The perception of subfertility developed by women with CF over time, before the era of modulators, can influence their long-term habi …
Surgical management and side effects of parotid gland surgery for benign lesions: a retrospective analysis of our experience from 2012 to 2021.
Committeri U, Arena A, Iaquino V, Salzano G, Blasi FD, Esposito M, Giovacchini F, Calvanese C, Abbate V, Bonavolontà P, Califano L, Orabona GD. Committeri U, et al. Among authors: blasi fd. Br J Oral Maxillofac Surg. 2023 Jul;61(6):411-415. doi: 10.1016/j.bjoms.2023.03.011. Epub 2023 Mar 31. Br J Oral Maxillofac Surg. 2023. PMID: 37365064

We found 19 capsular ruptures in patients undergoing ECD (5.34%) and five among those undergoing SP (2.52%) [p < 0,05]; 16 cases of temporary facial paralysis among those undergoing ECD (4.49%) and 35 in patients undergoing SP (17.67%) [p < 0,05]; and eight instances of per

…

We found 19 capsular ruptures in patients undergoing ECD (5.34%) and five among those undergoing SP (2.52%) [p < 0,05]; 16 cases of tempo

…
Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis.
Gramegna A, Majo F, Alicandro G, Leonardi G, Cristiani L, Amati F, Contarini M, Aliberti S, Fiocchi AG, Blasi F. Gramegna A, et al. Among authors: blasi f. Respir Res. 2023 Jun 17;24(1):164. doi: 10.1186/s12931-023-02451-0. Respir Res. 2023. PMID: 37330504 Free PMC article.
The treatment's effect on weight changes was evaluated using mixed effect regression models that included subject-specific random intercepts and fixed effects for potential predictors of treatment response, time and a predictor-by-time interaction term. RESULTS: The mean w …
The treatment's effect on weight changes was evaluated using mixed effect regression models that included subject-specific random intercepts …
Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis.
Alicandro G, Orena BS, Rosazza C, Cariani L, Russo M, Zatelli M, Badolato R, Gramegna A, Blasi F, Daccò V. Alicandro G, et al. Among authors: blasi f. Vaccine. 2023 Jun 23;41(28):4114-4120. doi: 10.1016/j.vaccine.2023.05.041. Epub 2023 May 22. Vaccine. 2023. PMID: 37263872 Free PMC article.
However, the role of the cell-mediated immune response in providing long-term protection against SARS-CoV-2 in pwCF has not yet been defined. ...
However, the role of the cell-mediated immune response in providing long-term protection against SARS-CoV-2 in pwCF has not yet been …
Bone Disease in Long-Term Lung Transplant Survivors.
Grassi G, Cairoli E, Gentile LMS, Chiodini I, Zampogna M, Ghielmetti A, Morlacchi LC, Rossetti V, Rosso L, Righi I, Nosotti M, Arosio M, Blasi F, Eller Vainicher C. Grassi G, et al. Among authors: blasi f. Life (Basel). 2023 Apr 1;13(4):928. doi: 10.3390/life13040928. Life (Basel). 2023. PMID: 37109457 Free PMC article.
The aim of our study is to compare the skeletal outcomes, after the first 2 years post-LTx, in long-term survivors with CF and nCF. MATERIALS AND METHODS: We evaluated the FX rate, the changes in bone mineral density (BMD) and trabecular bone score (TBS) in 68 patients (38 …
The aim of our study is to compare the skeletal outcomes, after the first 2 years post-LTx, in long-term survivors with CF and nCF. M …
58 results